文献速递心血管MR

系统性红斑狼疮患者心脏磁共振定量影像生物标志物的诊断与预后价值:系统综述与荟萃分析

Diagnostic and prognostic value of quantitative cardiac magnetic resonance imaging biomarkers in systemic lupus erythematosus: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2024-12-19

该系统综述与荟萃分析纳入64项研究共3304人(1870例SLE患者),其中19项病例对照研究进入比较荟萃分析(1576人,884例SLE患者)。与对照相比,SLE患者左室射血分数(62% vs. 64%,p=0.001)和 indexed 舒张末期容积(77 vs. 72 mL/m2,p=0.006)显著改变,晚期钆增强范围更高(3.5% vs. 1.1%,p=0.009),初始T1和T2弛豫时间显著升高。心肌组织特征参数显著改变并与疾病活动度相关,但心室功能与容积仅轻度差异。

要点

  • SLE患者初始T1和T2弛豫时间显著高于对照,提示心肌组织特征定量参数可用于检出亚临床心脏受累。
  • SLE患者晚期钆增强范围(LGE质量/总左室质量3.5% vs. 1.1%)显著高于对照。
  • 左室射血分数(62% vs. 64%)和 indexed 舒张末期容积(77 vs. 72 mL/m2)在SLE患者中显著改变但差异仅轻度。

核心结论

  • SLE患者心室功能与容积较对照仅轻度差异,而心肌组织特征参数显著改变并与疾病活动度相关;需要额外研究进一步证明CMR在SLE中的预后价值。

研究设计与样本

  • 系统综述与荟萃分析,系统检索电子数据库至2023年11月,遵循PRISMA指南,采用纽卡斯尔-渥太华质量评估量表评估偏倚风险;共纳入64项研究3304人(1870例SLE患者),其中19项病例对照研究(1576人,884例SLE患者)进入比较荟萃分析。

关键影像表现/征象

  • SLE患者左室射血分数低于对照(62% vs. 64%,p=0.001)。
  • SLE患者 indexed 舒张末期容积高于对照(77 vs. 72 mL/m2,p=0.006)。
  • SLE患者晚期钆增强范围高于对照(LGE质量/总左室质量3.5% vs. 1.1%,p=0.009)。
  • SLE患者初始T1弛豫时间高于对照(1.5 T:1005 vs. 982 ms,p=0.02;3 T:1267 vs. 1140 ms,p<0.001)。
  • SLE患者T2弛豫时间高于对照(所有场强:58 vs. 51 ms,p<0.001)。

诊断标准与关键数值

  • 3项研究发现疾病活动度与T2弛豫时间升高相关。
  • 2项研究识别出临床结局与CMR参数之间的关联。

临床应用与阅片要点

  • CMR成像可显示系统性红斑狼疮患者的亚临床心脏改变。
  • 心肌组织特征参数(初始T1、T2、LGE)在SLE患者中显著改变并与疾病活动度相关,阅片时可关注这些定量指标。
  • 心室功能与容积在SLE患者中仅轻度差异,判读时需结合组织特征参数综合评估。

局限性

  • 需要额外研究进一步证明CMR在SLE中的预后价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to compare CMR imaging biomarkers between SLE patients and matched controls.

MATERIALS AND METHODS: Electronic databases were systematically searched from inception until November 2023. All studies reporting CMR imaging data in SLE patients were included. PRISMA guidelines were followed, and risk of bias was assessed using the Newcastle-Ottawa Quality Assessment Scale. CMR findings of SLE patients were compared to that of matched controls. Clinical features associated with CMR biomarkers were collected in a qualitative analysis.

RESULTS: A total of 64 studies were included in the systematic review pooling 3304 individuals including 1870 SLE patients. Of these, 19 case-control studies were included in the comparative meta-analysis (1576 individuals, including 884 SLE patients). Compared to controls, left ventricular (LV) ejection fraction (62% vs. 64%, p = 0.001) and indexed end-diastolic volume (77 vs. 72 mL/m2, p = 0.006) were significantly altered in SLE patients. Late gadolinium enhancement (LGE) extent was higher in SLE patients (LGE mass/total LV mass: 3.5% vs. 1.1%, p = 0.009). Native T1 and T2 relaxation times were significantly higher in SLE patients (native T1 [1.5 T]: 1005 vs. 982 ms, p = 0.02; native T1 [3 T]: 1267 vs. 1140 ms, p < 0.001; T2 [all fields]: 58 vs. 51 ms, p < 0.001). Three studies found an association between disease activity and increased T2 relaxation times. Two studies identified an association between clinical outcomes and CMR parameters.

CONCLUSIONS: While CMR-assessed ventricular function and volumes only slightly differed in SLE patients when compared to controls, myocardial tissue characterization parameters were significantly modified and associated with disease activity.

KEY POINTS: Question What are the diagnostic and prognostic values of cardiac magnetic resonance (CMR) quantitative parameters in systemic lupus erythematosus (SLE) patients? Findings Myocardial tissue characterization parameters are significantly altered in SLE patients and associated with disease activity. Clinical relevance CMR imaging demonstrates subclinical cardiac alterations in systemic lupus erythematosus patients. Additional studies are required to further demonstrate the prognostic value of CMR in SLE.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Azoulay LD, Kachenoura N, Boussouar S, et al. Diagnostic and prognostic value of quantitative cardiac magnetic resonance imaging biomarkers in systemic lupus erythematosus: a systematic review and meta-analysis. Eur Radiol. 2024. PMID: 39699681. doi:10.1007/s00330-024-11282-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。